The latest news about psychopharmacology and drug research
A substance found in cannabis may be a faster-acting antidepressant than conventional medications. A new…
The link between cannabis use and psychological distress is stronger for women than men, according…
Studies have found an association between cannabis use and transient psychotic symptoms, such as unusual…
A new study provides evidence that regular caffeine consumption is associated with alterations in the…
A substance found in chili peppers reduces depressive symptoms in a rodent model of depression,…
New research helps identify some of the differences between the cognitive effects of classical hallucinogens…
Alcohol intoxication can impair the ability of witnesses to properly recall a person’s facial characteristics,…
The anti-anxiety effects of ketamine are associated with specific brainwave changes, according to research published…
Many people report persisting positive effects after receiving ibogaine-assisted detoxification for opioid addiction, but many…
New research provides evidence that a person’s religious beliefs can shape their experiences with psychedelic…
A new study sought to identify some of the potential psychological mechanisms that lead to smoking cessation in people who received psilocybin, the active compound in so-called magic mushrooms.
Synthetic cannabinoids can increase depression- and anxiety-like behaviors in a rodent model of trauma, according…
New research provides evidence that regular cannabis use is associated with impairments in episodic foresight, meaning the capacity to envision the future. The findings, which appear in the Journal of Psychopharmacology, suggest that cannabis can impair the ability to mentally travel into one’s personal future.
Cocaine enhances prospective memory performance, while cannabis tends to impair prospective memory, according to new…
New research provides evidence that cannabis users have a “noisier” brain compared to non-users. The…